Applications of next-generation sequencing technologies in functional genomics O Morozova, MA Marra Genomics 92 (5), 255-264, 2008 | 1691 | 2008 |
The genetic landscape of high-risk neuroblastoma TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, ... Nature genetics, 2013 | 1248 | 2013 |
Applications of new sequencing technologies for transcriptome analysis O Morozova, M Hirst, MA Marra Annual review of genomics and human genetics 10, 135-151, 2009 | 720 | 2009 |
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma KR Taylor, A Mackay, N Truffaux, YS Butterfield, O Morozova, C Philippe, ... Nature genetics 46 (5), 457-461, 2014 | 521 | 2014 |
SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells J Biernaskie, M Paris, O Morozova, BM Fagan, M Marra, L Pevny, ... Cell stem cell 5 (6), 610-623, 2009 | 421 | 2009 |
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers S Yip, YS Butterfield, O Morozova, S Chittaranjan, MD Blough, J An, I Birol, ... The Journal of Pathology, 2012 | 350 | 2012 |
Convergent Genesis of an Adult Neural Crest‐Like Dermal Stem Cell from Distinct Developmental Origins H Jinno, O Morozova, KL Jones, JA Biernaskie, M Paris, R Hosokawa, ... Stem Cells 28 (11), 2027-2040, 2010 | 138 | 2010 |
LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer T Romanuik, G Wang, O Morozova, A Delaney, M Marra, M Sadar BMC medical genomics 3 (1), 43, 2010 | 133 | 2010 |
Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth B Das, R Antoon, R Tsuchida, S Lotfi, O Morozova, W Farhat, D Malkin, ... Neoplasia (New York, NY) 10 (10), 1105, 2008 | 118 | 2008 |
Selective targeting of neuroblastoma tumour‐initiating cells by compounds identified in stem cell‐based small molecule screens KM Smith, A Datti, M Fujitani, N Grinshtein, L Zhang, O Morozova, ... EMBO Molecular Medicine 2 (9), 371-384, 2010 | 78 | 2010 |
Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression A Baradaran-Heravi, KS Cho, B Tolhuis, M Sanyal, O Morozova, ... Human molecular genetics 21 (11), 2572-2587, 2012 | 77 | 2012 |
Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma D Chand, Y Yamazaki, K Ruuth, C Schönherr, T Martinsson, P Kogner, ... Disease models & mechanisms 6 (2), 373-382, 2013 | 73 | 2013 |
A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer SM Nolte, C Venugopal, N McFarlane, O Morozova, RM Hallett, ... Journal of the National Cancer Institute 105 (8), 551-562, 2013 | 66 | 2013 |
System-Level Analysis of Neuroblastoma Tumor–Initiating Cells Implicates AURKB as a Novel Drug Target for Neuroblastoma O Morozova, M Vojvodic, N Grinshtein, LM Hansford, KM Blakely, ... Clinical cancer research 16 (18), 4572-4582, 2010 | 57 | 2010 |
From cytogenetics to next-generation sequencing technologies: advances in the detection of genome rearrangements in tumors This paper is one of a selection of papers published … O Morozova, MA Marra Biochemistry and Cell Biology 86 (2), 81-91, 2008 | 51 | 2008 |
Retinoblastoma-binding proteins 4 and 9 are important for human pluripotent stem cell maintenance MD O’Connor, E Wederell, G Robertson, A Delaney, O Morozova, ... Experimental hematology 39 (8), 866-879. e1, 2011 | 35 | 2011 |
DNA Hypermethylation and 1p Loss Silence NHE‐1 in Oligodendroglioma MD Blough, M Al‐Najjar, C Chesnelong, CE Binding, AD Rogers, ... Annals of Neurology, 2012 | 30 | 2012 |
Genomic analysis distinguishes phases of early development of the mouse atrio-ventricular canal P Vrljicak, ACY Chang, O Morozova, ED Wederell, K Niessen, MA Marra, ... Physiological genomics 40 (3), 150-157, 2010 | 23 | 2010 |
A Seriation Approach for Visualization-Driven Discovery of Co-Expression Patterns in Serial Analysis of Gene Expression (SAGE) Data O Morozova, V Morozov, BG Hoffman, CD Helgason, MA Marra PloS one 3 (9), e3205, 2008 | 5 | 2008 |
A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines. M Vojvodic, LM Hansford, O Morozova, KM Blakely, P Taylor, KE Fathers, ... Current drug discovery technologies, 2013 | 2 | 2013 |